Sardis Capital

Intelligence

Proprietary market formation monitoring. Specific commercial moves before the market prices them in.

What It Is

The System

Sardis Intelligence is a proprietary market formation monitoring system that watches regulatory, capital, and behavioral signals across healthcare AI, resilient infrastructure, AI licensing, and sovereign compute markets simultaneously.

Every week the system processes signals from government sources, funding announcements, research publications, and ecosystem movements — and translates them into specific commercial moves for named clients and named prospects before the market prices them in.

What It Produces

Three Outputs

01

Weekly Intelligence Briefs

Client intelligence briefs specific to your buyer landscape and commercial motion — delivered weekly, not when the news cycle catches up.

02

Ecosystem Activation Maps

Maps that show which buyers are turning on, which partnerships are being forced, and which revenue is being unlocked by current market signals.

03

Market Formation Predictions

Timestamped, dated, public, falsifiable calls on where sovereignty markets are heading — before the consensus forms.

Track Record

Market Formation Calls

Dated predictions posted publicly. The receipts are the proof.

September 28, 2026

Horizon: 12–24 months

Within 12–24 months, leading AI-infrastructure providers will increasingly finance and control multiple physical resource layers — power, data-center shells, cooling/water, and compute — as well as use long-duration contracted demand (TCV) to underwrite expansion, rather than operating as GPU-rental businesses alone.

Posted: September 28, 2026 — Sardis Capital

May 26, 2026

Confidence: 72%

By Q2 2028, the United States will adopt federal explainability requirements for high-risk clinical AI, following the EU AI Act template.

The mechanism: EU enforcement pressure on US-headquartered health AI companies operating in European markets will force domestic regulatory convergence faster than Congress can act independently.

Posted: May 26, 2026 — Sardis Capital

Intelligence access is available to active advisory clients. If you want commercial moves before the market prices them in, let's talk.

Initiate a Conversation

— A Letter of Intent

If you're building something that matters and the commercial layer isn't keeping up — let's talk.

Work with Sardis
SARDIS CAPITAL GROUP

Market intelligence, GTM advisory, ecosystem development, and selective co-investment for companies building in AI healthcare, resilient infrastructure, and AI infrastructure.

Contact

Start a conversation →LinkedIn

Sardis Capital Group is a GTM and ecosystem advisory firm. Nothing on this site constitutes investment advice. Engagements are subject to mutual qualification and availability.

© 2026 Sardis Capital Group. All rights reserved.Privacy · Terms · Regulatory